Prescription ID | TCMF218 |
Pinyin Name | San Jin Pian |
Chinese Name | 三金片 |
English Name | San Jin Tablet |
Function Description | 热淋 |
Indications | Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
Disease ICD-11 Category |
SA91 [Heat stranguria disorder (TM1), 热淋 (TM1)
]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的前列腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性前列腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾小管-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿道炎和尿道综合征 ]; |
Human Tissues Associated with Indication | Bladder |
Reference | Chinese pharmacopoeia (2015) |
Reference Book/link | ISBN 978-7-5067-7337-9 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1132 | Radix rosae laevigatae | 金樱根 | TCMH1132 | |
TCMH37 | Smilax china | 菝葜 | TCMH37 | CPBOL4044-11 |
TCMH2433 | Akebia puinata | 羊开口 | TCMH2433 | |
TCMH1118 | Lygodium japonicum | 金沙藤 | TCMH1118 | ITSAJ4232-14 |
TCMH1033 | Centella asiatica | 积雪草 | TCMH1033 | ITSAJ4523-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT197 | PDE4D | Phosphodiesterase 4D | Hydrolase | Q08499 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT22 | ALPI | Intestinal alkaline phosphatase | Hydrolase | P09923 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
TCMT359 | FYN | Tyrosine-protein kinase FYN | Kinase | P06241 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
TCMT698 | PDE4B | Phosphodiesterase 4B | Hydrolase | Q07343 |
TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
TCMT754 | GSTP1 | Glutathione S-transferase Pi | Transferase | P09211 |
TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT865 | GSTA1 | Glutathione S-transferase A1 | Transferase | P08263 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1189 | Pseudomonas fluorescens |
TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1218 | Staphylococcus aureus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1231 | Human herpesvirus 1 strain KOS |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1243 | Aspergillus flavus |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1296 | Influenza A virus H3N2 |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0006629 | lipid metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 11.5169 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PIK3CA, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR | 10.3522 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TEK, TYR | 10.0443 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TYR | 9.87184 |
[BP] GO:0008152 | metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APP, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 9.85935 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APP, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 9.4508 |
[BP] GO:0065008 | regulation of biological quality | ACHE, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 8.99737 |
[BP] GO:0010647 | positive regulation of cell communication | AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 8.87625 |
[BP] GO:0023056 | positive regulation of signaling | AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 8.87283 |
[BP] GO:0042127 | regulation of cell proliferation | AKR1B1, APP, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 8.11837 |
[BP] GO:0010941 | regulation of cell death | AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 8.11837 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SMAD3, SRC, TERT | 8.11532 |
[BP] GO:1902531 | regulation of intracellular signal transduction | AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 8.10682 |
[BP] GO:0043067 | regulation of programmed cell death | AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.98668 |
[BP] GO:0060548 | negative regulation of cell death | AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 7.98668 |
[BP] GO:0032502 | developmental process | ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TYR | 7.84918 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 7.77972 |
[BP] GO:0043069 | negative regulation of programmed cell death | AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 7.70122 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH | 7.54111 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC, TERT | 7.47743 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, PPARA, SMAD3, SRC, TEK, TYR | 7.38297 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 7.37708 |
[BP] GO:0042981 | regulation of apoptotic process | AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.32747 |
[BP] GO:0009967 | positive regulation of signal transduction | AKR1B1, APP, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.30729 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT | 7.24061 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH | 7.23418 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, HSPA1A, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH | 7.17558 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 7.17558 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 | 7.17558 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX5, ALPI, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 7.16092 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD17B2, PTGS2, RORC, SRC, TYR | 7.13795 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC, TEK, TYR | 7.11043 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | AKR1B1, APP, AXL, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 7.11043 |
[BP] GO:0043066 | negative regulation of apoptotic process | AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 7.05955 |
[BP] GO:0010646 | regulation of cell communication | ACHE, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 7.04441 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 6.95657 |
[BP] GO:0023051 | regulation of signaling | ACHE, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.92842 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, PPARA, PTGS2, SRC, TEK | 6.73296 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 6.69144 |
[BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK | 6.61723 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, PIK3CA, PTGS2, RORC, SMAD3, SRC | 6.54133 |
[BP] GO:0044238 | primary metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 6.40128 |
[BP] GO:0048856 | anatomical structure development | ACHE, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR | 6.149 |
[BP] GO:0032501 | multicellular organismal process | AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR | 6.12971 |
[BP] GO:0048584 | positive regulation of response to stimulus | AKR1B1, APP, AXL, CSNK2A1, CYP1B1, EGFR, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 6.11242 |
[BP] GO:0050896 | response to stimulus | ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR | 6.02001 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 | 5.95253 |
[BP] GO:0015701 | bicarbonate transport | CA12, CA14, CA2, CA4, CA7, CA9 | 5.95221 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.94719 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 5.89357 |
[BP] GO:0030335 | positive regulation of cell migration | APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.84661 |
[BP] GO:0042592 | homeostatic process | AKR1B1, APP, AXL, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC, TERT | 5.84614 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALPI, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.80377 |
[BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK | 5.71854 |
[BP] GO:2000147 | positive regulation of cell motility | APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.70807 |
[BP] GO:0019220 | regulation of phosphate metabolic process | APP, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.70208 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 5.65906 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | APP, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 5.65906 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR | 5.64759 |
[BP] GO:0051272 | positive regulation of cellular component movement | APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.61031 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH | 5.56783 |
[BP] GO:0040017 | positive regulation of locomotion | APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.46266 |
[BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK | 5.44793 |
[BP] GO:0080134 | regulation of response to stress | APP, CYP19A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.43297 |
[BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 5.38112 |
[BP] GO:0009966 | regulation of signal transduction | AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.32655 |
[BP] GO:0048583 | regulation of response to stimulus | AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.29729 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, PTGS2, TEK, TERT | 5.26823 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APP, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC | 5.25874 |
[BP] GO:0065009 | regulation of molecular function | APP, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.23259 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 5.21223 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 | 5.19683 |
[BP] GO:0030334 | regulation of cell migration | APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 5.14814 |
[BP] GO:0050790 | regulation of catalytic activity | APP, AURKB, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 5.13106 |
[BP] GO:0006979 | response to oxidative stress | AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC | 4.95681 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, PIK3CA, PIK3CB, SMAD3 | 4.93612 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TYR, XDH | 4.92295 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | APP, CDC25B, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 4.89965 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | APP, CDC25B, EGFR, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 4.89965 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC | 4.88571 |
[BP] GO:0006730 | one-carbon metabolic process | CA12, CA2, CA4, CA7, CA9 | 4.87914 |
[BP] GO:2000145 | regulation of cell motility | APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 4.84434 |
[BP] GO:0032879 | regulation of localization | ACHE, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 4.7533 |
[BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT | 4.7533 |
[BP] GO:0009628 | response to abiotic stimulus | AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, TYR | 4.64072 |
[BP] GO:0044092 | negative regulation of molecular function | APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC | 4.59613 |
[BP] GO:0042325 | regulation of phosphorylation | APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK, XDH | 4.58947 |
[BP] GO:0040012 | regulation of locomotion | APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 4.46252 |
[BP] GO:0051270 | regulation of cellular component movement | APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT | 4.44865 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR | 4.41227 |
[BP] GO:0001932 | regulation of protein phosphorylation | APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 4.39774 |
[BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 4.34145 |
[BP] GO:0031399 | regulation of protein modification process | APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 4.28135 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TEK, TYR | 4.25299 |
[BP] GO:0010038 | response to metal ion | APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2, TERT | 4.23865 |
[BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 4.18702 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.18267 |
[BP] GO:0001934 | positive regulation of protein phosphorylation | APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 4.18267 |
[BP] GO:0051247 | positive regulation of protein metabolic process | APP, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 4.16865 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR | 4.07129 |
[BP] GO:0019369 | arachidonic acid metabolic process | CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.07043 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.02225 |
[BP] GO:0042327 | positive regulation of phosphorylation | APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 3.97183 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 3.96693 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.9633 |
[BP] GO:1901652 | response to peptide | AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, PTGS2, SRC, TEK | 3.95391 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 3.94226 |
[BP] GO:0043549 | regulation of kinase activity | APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 3.93765 |
[BP] GO:0006950 | response to stress | ACHE, AKR1B1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT | 3.91212 |
[BP] GO:0001666 | response to hypoxia | CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT | 3.90612 |
[BP] GO:0043408 | regulation of MAPK cascade | APP, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH | 3.88899 |
[BP] GO:0051338 | regulation of transferase activity | APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 3.86708 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 | 3.84774 |
[BP] GO:0032270 | positive regulation of cellular protein metabolic process | APP, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 3.84774 |
[BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC | 3.83274 |
[BP] GO:0036293 | response to decreased oxygen levels | CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT | 3.82883 |
[BP] GO:0045787 | positive regulation of cell cycle | APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, SRC, TERT | 3.77369 |
[BP] GO:0044093 | positive regulation of molecular function | APP, AURKB, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 3.76682 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | APP, AURKB, CDC25B, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 3.7192 |
[BP] GO:0009893 | positive regulation of metabolic process | APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 3.7014 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 3.68325 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.68154 |
[BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, PTGS2, SRC, TEK | 3.66616 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 3.6439 |
[BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PTGS2, SRC, TEK | 3.63098 |
[BP] GO:0043085 | positive regulation of catalytic activity | APP, AURKB, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 3.60269 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD11B1, HSD17B1, HSD17B2 | 3.59806 |
[BP] GO:0070482 | response to oxygen levels | CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT | 3.58843 |
[BP] GO:0043410 | positive regulation of MAPK cascade | APP, EGFR, FLT3, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH | 3.58843 |
[BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT | 3.58496 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 3.5585 |
[BP] GO:1900182 | positive regulation of protein localization to nucleus | APP, EGFR, PTGS2, SMAD3, SRC, TERT | 3.5585 |
[BP] GO:0043393 | regulation of protein binding | APP, AURKB, MET, MMP9, PPARA, SRC, TERT | 3.5585 |
[BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 3.5579 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 | 3.557 |
[BP] GO:0031347 | regulation of defense response | CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK | 3.55142 |
[BP] GO:0080135 | regulation of cellular response to stress | APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH | 3.54527 |
[BP] GO:0045859 | regulation of protein kinase activity | APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 3.54527 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALPI, CSNK2A1, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB | 3.53732 |
[BP] GO:0009056 | catabolic process | ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH | 3.52175 |
[BP] GO:0032268 | regulation of cellular protein metabolic process | APP, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 3.50311 |
[BP] GO:0007346 | regulation of mitotic cell cycle | APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT | 3.49399 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 3.49245 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 3.4783 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.46641 |
[BP] GO:0001775 | cell activation | ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC | 3.46641 |
[BP] GO:0051049 | regulation of transport | ACHE, APP, AXL, CA2, CA7, CYP19A1, EGFR, GPR35, HSPA1A, INSR, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TERT | 3.46358 |
[BP] GO:0048585 | negative regulation of response to stimulus | CYP19A1, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH | 3.42068 |
[BP] GO:0044267 | cellular protein metabolic process | ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIK3CA, PIM1, PTPN1, SMAD3, SRC, TEK | 3.41694 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APP, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC | 3.37206 |
[BP] GO:0045931 | positive regulation of mitotic cell cycle | APP, CDC25B, CYP1A1, DUSP3, INSR, TERT | 3.35922 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC | 3.34588 |
[BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, PTGS2, TYR | 3.34203 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 3.33263 |
[BP] GO:0071248 | cellular response to metal ion | CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 3.30678 |
[BP] GO:0051726 | regulation of cell cycle | APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC, TERT | 3.30551 |
[BP] GO:0051130 | positive regulation of cellular component organization | APP, AURKB, AXL, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK | 3.28631 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, HSD17B2, INSR, MMP2, MMP9, PTGS2, SRC | 3.25254 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 3.2023 |
[BP] GO:0043405 | regulation of MAP kinase activity | DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC | 3.19487 |
[BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, INSR, PTGS2, SMAD3 | 3.18835 |
[BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 3.18835 |
[BP] GO:0048732 | gland development | CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR | 3.17712 |
[BP] GO:0051098 | regulation of binding | APP, AURKB, MET, MMP9, PPARA, SMAD3, SRC, TERT | 3.17566 |
[BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, INSR, PTGS2, SMAD3, XDH | 3.17384 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 3.15886 |
[BP] GO:0031401 | positive regulation of protein modification process | APP, CDC25B, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH | 3.15501 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, CDC25B, CYP1A1, EGFR, ESR1, FABP4, FLT3, FUT7, KDR, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, TEK, TERT | 3.12459 |
[BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 3.12147 |
[BP] GO:0006464 | cellular protein modification process | ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PTPN1, SMAD3, SRC, TEK | 3.11672 |
[BP] GO:0036211 | protein modification process | ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PTPN1, SMAD3, SRC, TEK | 3.11672 |
[BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, CDC25B, CYP19A1, EGFR, ESR1, HSD17B2, INSR, PTGS2, SRC | 3.10235 |
[BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | HSPA1A, MMP9, PTGS2, PTPN1, SRC | 3.08078 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 3.07793 |
[BP] GO:0001525 | angiogenesis | CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK | 3.05303 |
[BP] GO:2000377 | regulation of reactive oxygen species metabolic process | CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH | 3.03335 |
[BP] GO:0019216 | regulation of lipid metabolic process | CYP1A1, FABP3, FLT3, PPARA, PTGS2, RORC, SRC, TEK | 3.03335 |
[BP] GO:0051246 | regulation of protein metabolic process | APP, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH | 3.02927 |
[BP] GO:0071241 | cellular response to inorganic substance | CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 | 2.99736 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 2.99258 |
[BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.9803 |
[BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.9803 |
[BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.9803 |
[BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.9803 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 2.9803 |
[BP] GO:0001952 | regulation of cell-matrix adhesion | KDR, PIK3CB, SMAD3, SRC, TEK | 2.94148 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.92583 |
[BP] GO:0070920 | None | EGFR, ESR1, TERT | 2.92583 |
[BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | APP, DUSP3, EGFR, KDR, PTPN1, SRC, TEK | 2.89238 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.87033 |
[BP] GO:0050727 | regulation of inflammatory response | CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, SMAD3, TEK | 2.85823 |
[BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.85113 |
[BP] GO:0002009 | morphogenesis of an epithelium | CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.82634 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CYP1B1, EGFR, KDR, PTGS2, SRC | 2.82634 |
[BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SRC | 2.81138 |
[BP] GO:0048511 | rhythmic process | AXL, CSNK2A1, EGFR, ESR1, PPARA, RORC, SRC | 2.81015 |
[BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.79626 |
[BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.79626 |
[BP] GO:0001503 | ossification | ALPL, EGFR, MMP2, MMP9, TEK | 2.75895 |
[BP] GO:0050801 | ion homeostasis | APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, PIK3CB, SMAD3 | 2.75895 |
[BP] GO:0030155 | regulation of cell adhesion | CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK | 2.75895 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.75052 |
[BP] GO:0046686 | response to cadmium ion | CYP1A2, EGFR, MMP9, TERT | 2.74193 |
[BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AXL, CA2, CYP1B1, EGFR, HSPA1A, KDR, MET, MMP9, PIM1, PTGS2, SMAD3, SRC, TEK, TERT | 2.72416 |
[BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.71986 |
[BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, INSR, PTGS2, SMAD3 | 2.71986 |
[BP] GO:0007166 | cell surface receptor signaling pathway | APP, AXL, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK | 2.70249 |
[BP] GO:0016477 | cell migration | AXL, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK | 2.69895 |
[BP] GO:0051347 | positive regulation of transferase activity | AURKB, CDC25B, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 2.68996 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.68397 |
[BP] GO:0015711 | organic anion transport | CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 2.67129 |
[BP] GO:0033674 | positive regulation of kinase activity | CDC25B, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 2.67129 |
[BP] GO:0050806 | positive regulation of synaptic transmission | APP, CA2, CA7, EGFR, PTGS2 | 2.66425 |
[BP] GO:0009968 | negative regulation of signal transduction | DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH | 2.65972 |
[BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH | 2.63227 |
[BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.61916 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.61916 |
[BP] GO:0040011 | locomotion | AXL, CYP1B1, EGFR, FUT7, KDR, MET, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK | 2.60967 |
[BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SRC | 2.60967 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR | 2.60763 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 | 2.5926 |
[BP] GO:2001234 | negative regulation of apoptotic signaling pathway | HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT | 2.58512 |
[BP] GO:0009888 | tissue development | ALPL, CYP1B1, INSR, KDR, PIK3CA, PPARA, PTGS2, RORC, SMAD3 | 2.5792 |
[BP] GO:0050793 | regulation of developmental process | APP, AXL, CA2, CYP1B1, EGFR, ESR1, INSR, KDR, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.57783 |
[BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | MMP2, MMP9, TERT | 2.56916 |
[BP] GO:0009892 | negative regulation of metabolic process | APP, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH | 2.5489 |
[BP] GO:0010632 | regulation of epithelial cell migration | KDR, MET, MMP9, PTGS2, SRC, TEK | 2.5489 |
[BP] GO:0032872 | regulation of stress-activated MAPK cascade | APP, DUSP3, EGFR, IGF1R, PTPN1, XDH | 2.5489 |
[BP] GO:0070302 | regulation of stress-activated protein kinase signaling cascade | APP, DUSP3, EGFR, IGF1R, PTPN1, XDH | 2.54155 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 2.54106 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.52176 |
[BP] GO:0048545 | response to steroid hormone | ALPL, CA2, EGFR, FLT3, PTGS2, SRC | 2.51492 |
[BP] GO:1900180 | regulation of protein localization to nucleus | APP, EGFR, PTGS2, SMAD3, SRC, TERT | 2.4944 |
[BP] GO:0042493 | response to drug | AKR1B1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, PTGS2, SRC | 2.47374 |
[BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.47374 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.47374 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, EGFR, PIK3CB, PTGS2 | 2.44776 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.43859 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.43859 |
[BP] GO:0051248 | None | APP, CSNK2A1, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH | 2.43289 |
[BP] GO:0006650 | glycerophospholipid metabolic process | ACHE, ALPI, CSNK2A1, EGFR, MET, PIK3CA, PIK3CB | 2.43289 |
[BP] GO:0043412 | macromolecule modification | ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, PTPN1, SMAD3, SRC, TEK | 2.4269 |
[BP] GO:0009894 | regulation of catabolic process | CSNK2A1, EGFR, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1, SMAD3 | 2.40529 |
[BP] GO:0048870 | cell motility | AXL, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK | 2.39534 |
[BP] GO:1903725 | regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.39448 |
[BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.38867 |
[BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH | 2.36368 |
[BP] GO:0051128 | regulation of cellular component organization | APP, AURKB, AXL, CSNK2A1, EGFR, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PTPN1, SMAD3, SRC, TEK | 2.35539 |
[BP] GO:0032844 | regulation of homeostatic process | AURKB, CA2, CA7, EGFR, KDR, PIK3CB, PTGS2, SRC | 2.34889 |
[BP] GO:0010638 | positive regulation of organelle organization | AURKB, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 2.3479 |
[BP] GO:0050900 | leukocyte migration | FUT7, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK | 2.33339 |
[BP] GO:0032787 | None | ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 | 2.329 |
[BP] GO:0031100 | animal organ regeneration | AXL, CSNK2A1, EGFR, FLT3 | 2.31638 |
[BP] GO:0048729 | tissue morphogenesis | CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.30942 |
[BP] GO:0044089 | positive regulation of cellular component biogenesis | ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK | 2.29188 |
[BP] GO:0071363 | cellular response to growth factor stimulus | APP, EGFR, INSR, KDR, SMAD3, SRC | 2.29187 |
[BP] GO:0032101 | regulation of response to external stimulus | CYP19A1, EGFR, ESR1, FABP4, KDR, MET, PPARA, PTGS2, SMAD3, TEK | 2.28777 |
[BP] GO:0033280 | response to vitamin D | ALPL, PTGS2, TYR | 2.26979 |
[BP] GO:0009653 | anatomical structure morphogenesis | APP, AXL, CA2, CA9, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK | 2.26134 |
[BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, KDR, PTGS2, TEK, TERT | 2.25714 |
[BP] GO:0031960 | response to corticosteroid | ALPL, EGFR, FLT3, PTGS2, SRC | 2.24518 |
[BP] GO:0051050 | positive regulation of transport | ACHE, APP, AXL, CA2, CYP19A1, EGFR, INSR, PTGS2, SMAD3, SRC, TERT | 2.24071 |
[BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, SRC, TEK | 2.23714 |
[BP] GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | FLT3, SRC, TEK | 2.23714 |
[BP] GO:0042743 | hydrogen peroxide metabolic process | CYP1A1, CYP1A2, EGFR | 2.23714 |
[BP] GO:0098771 | inorganic ion homeostasis | APP, CA12, CA2, CA7, EGFR, ESR1, GPR35, PIK3CB, SMAD3 | 2.23714 |
[BP] GO:0051239 | regulation of multicellular organismal process | APP, AXL, CA2, CYP1B1, EGFR, ESR1, GPR35, HSPA1A, INSR, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH | 2.23714 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, EGFR, INSR, PTGS2, SMAD3 | 2.22147 |
[BP] GO:1903426 | None | EGFR, INSR, PTGS2, SMAD3 | 2.22147 |
[BP] GO:1901888 | regulation of cell junction assembly | KDR, SMAD3, SRC, TEK | 2.22147 |
[BP] GO:0008286 | None | IGF1R, INSR, PIK3CA, PTPN1 | 2.22147 |
[BP] GO:2001242 | regulation of intrinsic apoptotic signaling pathway | HSPA1A, MMP9, PTGS2, PTPN1, SRC | 2.22147 |
[BP] GO:0071900 | regulation of protein serine/threonine kinase activity | DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC | 2.21836 |
[BP] GO:1901890 | None | KDR, SMAD3, TEK | 2.21015 |
[BP] GO:0071276 | cellular response to cadmium ion | CYP1A2, EGFR, MMP9 | 2.21015 |
[BP] GO:2000352 | None | KDR, TEK, TERT | 2.21015 |
[BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | IGF1R, PIK3CA, PIK3CB | 2.21015 |
[BP] GO:1901989 | None | APP, CDC25B, CYP1A1, TERT | 2.19251 |
[BP] GO:0031324 | negative regulation of cellular metabolic process | APP, AURKB, CSNK2A1, DUSP3, ESR1, FABP4, HSPA1A, IGF1R, MET, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH | 2.1875 |
[BP] GO:0022900 | electron transport chain | AKR1B1, CYP19A1, CYP1A2, NQO2, XDH | 2.18414 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.17962 |
[BP] GO:0010595 | positive regulation of endothelial cell migration | KDR, MET, PTGS2, TEK | 2.17746 |
[BP] GO:0045860 | positive regulation of protein kinase activity | CDC25B, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC | 2.16957 |
[BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, ALPI, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 2.16833 |
[BP] GO:2001233 | regulation of apoptotic signaling pathway | HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT | 2.16833 |
[BP] GO:0043406 | positive regulation of MAP kinase activity | EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC | 2.16371 |
[BP] GO:0090218 | positive regulation of lipid kinase activity | FLT3, SRC, TEK | 2.14742 |
[BP] GO:1902893 | None | PPARA, SMAD3, TERT | 2.14742 |
[BP] GO:0010907 | None | INSR, PPARA, SRC | 2.14742 |
[BP] GO:0106027 | None | APP, IGF1R, INSR | 2.14742 |
[BP] GO:0010605 | negative regulation of macromolecule metabolic process | APP, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH | 2.1372 |
[BP] GO:1990535 | None | APP, INSR | 2.13593 |
[BP] GO:0048608 | reproductive structure development | AXL, CYP19A1, ESR1, HSD17B2, INSR, SRC | 2.12469 |
[BP] GO:0016042 | lipid catabolic process | AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 | 2.12469 |
[BP] GO:0051336 | regulation of hydrolase activity | APP, CSNK2A1, EGFR, ESR1, HSPA1A, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, XDH | 2.12407 |
[BP] GO:0046328 | regulation of JNK cascade | APP, DUSP3, EGFR, IGF1R, PTPN1 | 2.12306 |
[BP] GO:0006928 | movement of cell or subcellular component | APP, AXL, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK | 2.11697 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A | 2.113 |
[BP] GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, MMP9, PTGS2, SRC | 2.10734 |
[BP] GO:0090068 | positive regulation of cell cycle process | APP, AURKB, CDC25B, CYP1A1, INSR, TERT | 2.09686 |
[BP] GO:0080090 | regulation of primary metabolic process | APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.09517 |
[BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, EGFR, ESR1, FABP3, IGF1R, INSR, KDR, MET, PPARA, PTGS2, RORC, SMAD3, SRC, TERT | 2.08108 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.07571 |
[BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CYP1A1, CYP1A2, PTGS2, SRC | 2.07571 |
[BP] GO:0052548 | None | APP, CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH | 2.0738 |
[BP] GO:0043434 | None | FABP3, INSR, PPARA, PTGS2, SRC, TEK | 2.06947 |
[BP] GO:1904018 | positive regulation of vasculature development | CYP1B1, KDR, PTGS2, TEK, TERT | 2.06591 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, PIM1, PPARA, RORC, SRC | 2.06591 |
[BP] GO:0032103 | positive regulation of response to external stimulus | EGFR, FABP4, KDR, MET, PTGS2, SMAD3 | 2.06552 |
[BP] GO:0070848 | response to growth factor | APP, EGFR, INSR, KDR, SMAD3, SRC | 2.06552 |
[BP] GO:0045124 | None | CA2, EGFR, SRC | 2.06278 |
[BP] GO:0051172 | None | APP, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, XDH | 2.06278 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, KDR, SRC | 2.06278 |
[BP] GO:0009987 | cellular process | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, APP, AURKB, AXL, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 2.05809 |
[BP] GO:0031323 | regulation of cellular metabolic process | ACHE, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.05179 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR | 2.04547 |
[BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, EGFR, SRC | 2.0415 |
[BP] GO:0006820 | anion transport | CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA | 2.04126 |
[BP] GO:0034405 | response to fluid shear stress | CA2, PTGS2, SRC | 2.03752 |
[BP] GO:0046456 | icosanoid biosynthetic process | ALOX5, PTGS1, PTGS2 | 2.03752 |
[BP] GO:0009611 | response to wounding | ACHE, CYP1A1, EGFR, PPARA, SMAD3 | 2.03564 |
[BP] GO:0006644 | phospholipid metabolic process | ACHE, ALPI, CSNK2A1, EGFR, MET, PIK3CA, PIK3CB | 2.03096 |
[BP] GO:0010906 | None | INSR, PPARA, RORC, SRC | 2.03024 |
[BP] GO:0048609 | multicellular organismal reproductive process | AKR1B1, APP, AXL, CYP1A1, EGFR, ESR1, PTGS2, SRC | 2.02505 |
[BP] GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | EGFR, FLT3, KDR, TEK | 2.0161 |
[BP] GO:0016101 | None | AKR1B10, CYP1A1, CYP1B1, EGFR | 2.0161 |
[BP] GO:0048806 | genitalia development | AXL, CYP19A1, ESR1 | 2.01457 |
[BP] GO:0007566 | embryo implantation | MMP2, MMP9, PTGS2 | 2.01457 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, TYR | 2.00609 |
[BP] GO:0042307 | positive regulation of protein import into nucleus | APP, EGFR, PTGS2, SMAD3 | 2.00319 |
[CC] GO:0005886 | plasma membrane | ACHE, ALPI, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, ESR1, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SMAD3, SRC, TEK, TERT | 3.08078 |
[CC] GO:0016020 | membrane | ACHE, ALOX5, ALPI, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TYR | 2.90261 |
[CC] GO:0045121 | membrane raft | APP, EGFR, INSR, KDR, PTGS2, SRC, TEK | 2.73707 |
[CC] GO:0098857 | membrane microdomain | APP, EGFR, INSR, KDR, PTGS2, SRC, TEK | 2.72156 |
[CC] GO:0098589 | membrane region | APP, EGFR, INSR, KDR, PTGS2, SRC, TEK | 2.31503 |
[CC] GO:0044444 | cytoplasmic part | ACHE, AKR1B1, AKR1B10, ALOX5, APP, AURKB, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TERT, TYR, XDH | 2.27475 |
[CC] GO:0044425 | membrane part | ACHE, ALPI, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SRC, TEK, TYR | 2.20958 |
[CC] GO:0097443 | sorting endosome | KDR, PTPN1 | 2.13593 |
[MF] GO:0003824 | catalytic activity | ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TEK, TERT, TYR, XDH | 12.4215 |
[MF] GO:0043167 | ion binding | ACHE, ALOX5, ALPI, ALPL, APP, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH | 12.0442 |
[MF] GO:0046914 | transition metal ion binding | ALOX5, ALPI, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH | 11.5169 |
[MF] GO:0004089 | carbonate dehydratase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 8.43164 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.98668 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 7.30729 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TEK | 7.16092 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH | 6.17762 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK | 6.02028 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK | 5.89215 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 5.84195 |
[MF] GO:0008270 | zinc ion binding | ALPI, CA12, CA2, CA4, CA7, CA9, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC, SMAD3 | 5.67728 |
[MF] GO:0043169 | cation binding | ACHE, ALOX5, ALPI, ALPL, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, TERT, TYR, XDH | 5.54513 |
[MF] GO:0016836 | hydro-lyase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 5.46851 |
[MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 5.42199 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TERT | 5.34222 |
[MF] GO:0043560 | insulin receptor substrate binding | IGF1R, INSR, PIK3CA, PIK3CB | 5.27268 |
[MF] GO:0046872 | metal ion binding | ALOX5, ALPI, ALPL, APP, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, TERT, TYR, XDH | 5.1962 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 4.77534 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC | 4.7533 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC | 4.54563 |
[MF] GO:0042562 | hormone binding | ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 | 4.48123 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR | 4.23865 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 4.02786 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.84774 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH | 3.77369 |
[MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.57577 |
[MF] GO:0036094 | small molecule binding | AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH | 3.5728 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, XDH | 3.47654 |
[MF] GO:0005524 | ATP binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 3.46358 |
[MF] GO:0043168 | anion binding | APP, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH | 3.43365 |
[MF] GO:0000166 | nucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH | 3.35922 |
[MF] GO:1901265 | nucleoside phosphate binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH | 3.35922 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 3.35482 |
[MF] GO:0032559 | adenyl ribonucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 3.35482 |
[MF] GO:0030554 | adenyl nucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 3.32706 |
[MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PTPN1, SRC, TEK | 3.24769 |
[MF] GO:0005506 | iron ion binding | ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH | 3.14255 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR | 3.08078 |
[MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 3.07774 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.06 |
[MF] GO:0042802 | identical protein binding | ACHE, APP, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, KDR, MET, MMP9, NQO2, PTGS2, SMAD3, TERT, TYR, XDH | 3.01176 |
[MF] GO:0032403 | protein complex binding | ACHE, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC | 2.86756 |
[MF] GO:0016829 | lyase activity | CA12, CA14, CA2, CA4, CA7, CA9 | 2.85823 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, NQO2, XDH | 2.85806 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 | 2.68996 |
[MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.67372 |
[MF] GO:0019838 | growth factor binding | EGFR, IGF1R, INSR, KDR, TEK | 2.54155 |
[MF] GO:0035639 | purine ribonucleoside triphosphate binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 2.54155 |
[MF] GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | EGFR, MET, PIK3CA, PIK3CB | 2.51541 |
[MF] GO:0052813 | phosphatidylinositol bisphosphate kinase activity | EGFR, MET, PIK3CA, PIK3CB | 2.44826 |
[MF] GO:0051425 | None | APP, INSR | 2.43859 |
[MF] GO:0032555 | purine ribonucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 2.43835 |
[MF] GO:0017076 | purine nucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 2.4102 |
[MF] GO:0032553 | ribonucleotide binding | AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 2.40464 |
[MF] GO:0035004 | phosphatidylinositol 3-kinase activity | EGFR, MET, PIK3CA, PIK3CB | 2.35342 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD17B1, HSD17B2 | 2.34687 |
[MF] GO:1901363 | heterocyclic compound binding | APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.31503 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD17B1, HSD17B2 | 2.26979 |
[MF] GO:0043548 | phosphatidylinositol 3-kinase binding | AXL, IGF1R, INSR | 2.26979 |
[MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.26095 |
[MF] GO:0097367 | carbohydrate derivative binding | APP, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK | 2.23247 |
[MF] GO:0005158 | None | IGF1R, PTPN1, SRC | 2.21015 |
[MF] GO:0019899 | enzyme binding | ALPI, APP, AURKB, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, HSPA1A, MET, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK | 2.20664 |
[MF] GO:0019902 | phosphatase binding | EGFR, MET, PPARA, PTPN1, SMAD3 | 2.16643 |
[MF] GO:0004035 | alkaline phosphatase activity | ALPI, ALPL | 2.13593 |
[MF] GO:0035258 | None | ESR1, FLT3, SMAD3, SRC | 2.13582 |
[MF] GO:0097159 | organic cyclic compound binding | APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, XDH | 2.12469 |
[MF] GO:0001221 | transcription cofactor binding | ESR1, PPARA, TERT | 2.03752 |
[MF] GO:0005021 | vascular endothelial growth factor-activated receptor activity | FLT3, KDR | 2.03096 |
[MF] GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity | PIK3CA, PIK3CB | 2.03096 |
[MF] GO:0030235 | nitric-oxide synthase regulator activity | EGFR, ESR1 | 2.03096 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 11.7291 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 8.8309 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PIK3CB, MMP9, MET, ESR1, EGFR, IGF1R | 8.1284 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, EGFR, HSPA1A | 8.0999 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA2, CA4, CA7, CA9, CA14 | 9.4768 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 8.1284 |
Pathways in cancer_Homo sapiens_hsa05200 | SMAD3, PIK3CA, FLT3, MMP1, MMP2, PIK3CB, PTGS2, MMP9, MET, EGFR, IGF1R | 6.7349 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 6.838 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, INSR, PIK3CB, PTGS2, PTGS1 | 6.7349 |
Metabolic pathways_Homo sapiens_hsa01100 | AKR1B1, PTGS2, TYR, CYP19A1, PTGS1, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, ALPI, XDH | 5.6366 |
Ras signaling pathway_Homo sapiens_hsa04014 | PIK3CA, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 5.565 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 5.8233 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, INSR, TEK, PIK3CB, EGFR, IGF1R | 5.3072 |
VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PIK3CB, PTGS2 | 5.0882 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, INSR, PIK3CB, IGF1R, HSPA1A | 5.0131 |
Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, PIK3CB, MET, EGFR, IGF1R | 4.8831 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | PIK3CA, PIM1, CYP1B1, PTGS2, MMP9, MET, EGFR, CDC25B | 4.8831 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | PIK3CA, INSR, KDR, TEK, PIK3CB, MET, EGFR, IGF1R | 4.5024 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, PIK3CB, MET, EGFR | 4.9412 |
Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, EGFR, IGF1R | 4.8831 |
FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, PIK3CA, INSR, PIK3CB, EGFR, IGF1R | 4.8413 |
Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 4.3018 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, MMP2, PIM1, PIK3CB | 4.2348 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, PTGS2 | 4.6221 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, INSR, PIK3CB, PPARA | 4.0911 |
Glioma_Homo sapiens_hsa05214 | PIK3CA, PIK3CB, EGFR, IGF1R | 3.7357 |
Hepatitis B_Homo sapiens_hsa05161 | SMAD3, PIK3CA, SRC, PIK3CB, MMP9 | 3.5875 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.9462 |
Pancreatic cancer_Homo sapiens_hsa05212 | SMAD3, PIK3CA, PIK3CB, EGFR | 3.7251 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PIK3CB, PTGS2, EGFR | 3.4636 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1 | 3.6061 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP1A2, CYP1A1, CYP1B1 | 3.5967 |
Prostate cancer_Homo sapiens_hsa05215 | PIK3CA, PIK3CB, EGFR, IGF1R | 3.3371 |
ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PIK3CB, EGFR | 3.3635 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.6641 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PIK3CB, CDC25B, IGF1R | 3.1979 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 3.5109 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, INSR, PIK3CB, IGF1R | 3.2566 |
TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 3.0373 |
Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5, PTGS2, PTGS1 | 3.0175 |
Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.9237 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PIK3CB, ESR1 | 2.9698 |
Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, PIK3CB, HSPA1A | 2.9698 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PIK3CB, MMP9 | 2.9698 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, INSR, PIK3CB, IGF1R | 2.9059 |
Measles_Homo sapiens_hsa05162 | CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 2.7883 |
Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA, EGFR | 2.8167 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, PIK3CA, PIK3CB, IGF1R | 2.7418 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, INSR, PIK3CB | 2.761 |
Phospholipase D signaling pathway_Homo sapiens_hsa04072 | PIK3CA, INSR, PIK3CB, EGFR | 2.7418 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, INSR, PIK3CB, PPARA | 2.6792 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, PIK3CB, HSPA1A | 2.2623 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 2.4182 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB, EGFR | 2.1908 |
MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.9562 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, PIK3CB | 2.2415 |
HTLV-I infection_Homo sapiens_hsa05166 | SMAD3, PIK3CA, TERT, PIK3CB | 1.9439 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 2.3204 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.909 |
Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PIK3CB, EGFR | 2.2107 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | PIK3CA, PIK3CB, EGFR | 2.8167 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, PIK3CB | 2.125 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, PIM1, PIK3CB | 1.7349 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3, PIK3CA, PIK3CB | 2.187 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | SMAD3, PIK3CA, PIK3CB | 2.569 |
Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, PIK3CB, PTGS2 | 2.3774 |
Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, INSR, PIK3CB | 2.9698 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, INSR, PIK3CB | 1.6753 |
Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB, EGFR | 2.9 |
Influenza A_Homo sapiens_hsa05164 | PIK3CA, PIK3CB, HSPA1A | 1.6364 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | GPR35 | 0.2655 |
Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 2.6792 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB | 1.5777 |
Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 1.4936 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | PIK3CA, INSR, PIK3CB | 3.1754 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.3963 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3884 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSPA1A | 0.4072 |
cAMP signaling pathway_Homo sapiens_hsa04024 | PIK3CA, PIK3CB, PPARA | 1.5229 |
Calcium signaling pathway_Homo sapiens_hsa04020 | EGFR | 0.3947 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.3954 |
Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.4072 |
Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, PIK3CA, PIK3CB | 2.7418 |
Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.4355 |
Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.4794 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 2.6515 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4957 |
Apoptosis_Homo sapiens_hsa04210 | PIK3CA, PIK3CB | 1.0864 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.5042 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 1.0878 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, PIK3CB | 1.052 |
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PIK3CB | 1.1061 |
Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 1.0796 |
Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 1.1194 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, PIK3CB | 1.185 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, PIK3CB | 1.185 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, PTGS2, PTGS1 | 2.7418 |
Cell cycle_Homo sapiens_hsa04110 | SMAD3, CDC25B | 1.1636 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, CYP1B1 | 3.153 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.5741 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 1.2739 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.5741 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.5847 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 1.2847 |
Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | PTGS2 | 0.5741 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.584 |
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PIK3CB | 1.3606 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PIK3CB | 1.3115 |
Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PIK3CB | 1.3232 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.6075 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.6075 |
TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.6189 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 1.3779 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.6064 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, PTGS2 | 1.3606 |
Gap junction_Homo sapiens_hsa04540 | SRC, EGFR | 1.3914 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.6202 |
Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.6602 |
Antigen processing and presentation_Homo sapiens_hsa04612 | HSPA1A | 0.6461 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.6582 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.6698 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.5291 |
Bile secretion_Homo sapiens_hsa04976 | CA2 | 0.6676 |
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PIK3CB | 1.5777 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2 | 0.672 |
Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.5471 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.6921 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.7203 |
mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PIK3CB | 1.656 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.605 |
Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3, RORC | 1.605 |
Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.7518 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.6647 |
Malaria_Homo sapiens_hsa05144 | MET | 0.7948 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.8083 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.8133 |
Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.8755 |
Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.9219 |
Tyrosine metabolism_Homo sapiens_hsa00350 | TYR | 0.9219 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.965 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 1.011 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | CYP1A2 | 0.9851 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 2.1812 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 2.0425 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 2.1316 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 1.0191 |
Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.9747 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 1.011 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 2.3673 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL, ALPI | 2.7418 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.4684 |